Background: Detection and registration of high risk for cardiovascular diseases (CVD) by assessing individual’s absolute cardiovascular risk is recommended in clinical guidelines. Effective interventions to reduce cardiovascular risk are available, but not optimally implemented. The aim of this study was to assess the quality of cardiovascular risk-factor recording and lifestyle counselling in high-risk patients in European primary care and to identify factors related to these clinical processes.
Methods: An international cross-sectional observational study was conducted in stratified samples of primary care practices in nine European countries. Patient records were audited, using a structured data-abstraction tool based on internationally developed quality indicators. To identify factors associated with the recording, additional data were collected in a patient survey. Descriptive and multilevel data analyses were conducted.
Results: In 268 general practices across Europe, 3723 records of individuals at high risk for cardiovascular diseases were audited. We found important variations in the quality of documentation of risk factors and lifestyle interventions. Recording of risk factors was best for blood pressure (92.5% of audited records, 95% CI 0.89–0.96). Lifestyle advice was recorded best for smoking cessation (65.6%, 95% CI 0.58–0.73) and worst for physical activity (38.8%, 95% CI 0.31–0.47). Of the study population, 50.6% (0.42–0.59) had elevated blood pressure levels, 59.8% (0.51–0.69) had total cholesterol >5 mmol/l, and 30.5% (0.22–0.39) were smokers. Multivariate analyses showed that recording of risk factors and counselling were related to specific patient characteristics more than to country effects.
Conclusions: Analysis of different country results can be helpful for developing quality-improvement strategies.
AllenderSScharbotoughPPetoVRaynerMLealJLuengo-FernadezR. European cardiovascular disease statistics 2008. Oxford: British Heart Foundation, 2008.
2.
RaynerMAllenderSScarboroughP. Cardiovascular disease in Europe. Eur J Cardiovasc Prev Rehabil2009; 16 Suppl 2: S43–S47.
3.
GrahamIM. Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol2005; 20(5): 430–439.
4.
LopezADMathersCDEzzatiMJamisonDTMurrayCJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet2006; 367(9524): 1747–1757.
5.
GrahamIAtarDBorch-JohnsenKBoysenGBurellGCifkovaR. European guidelines on cardiovascular disease prevention in clinical practice: full text. Eur J Cardiovasc Prev Rehabil2007; 14 Suppl 2: S1–S113.
6.
KotsevaKWoodDDe BackerGDe BacquerDPyoralaKKeilU. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet2001; 357(9261): 995–1001.
7.
KotsevaKWoodD. The challenge for preventive cardiology. Eur J Cardiovasc Prev Rehabil2009; 16 Suppl 2: S19–S23.
8.
RouseAAdabP. Is population coronary heart disease risk screening justified? A discussion of the National Service Framework for coronary heart disease. Br J Gen Pract2001; 51(471): 834–837.
9.
PerkJ. Risk factor management: a practice guide. Eur J Cardiovasc Prev Rehabil2009; 16 Suppl 2: S24–S28.
10.
Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. National Clinical Guideline 97. Edinburgh: SIGN, 2007.
11.
World Health Organization. Prevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk. Geneva: WHO, 2007.
12.
CooperANhereraLCalvertNO’FlynnNTurnbullNRobsonJ. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2008.
13.
National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovascular disease risk. Australia: National Heart Foundation of Australia, 2009.
14.
CampbellSMLudtSVan LieshoutJBoffinNWensingMPetekD. Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries. Eur J Cardiovasc Prev Rehabil2008; 15(5): 509–515.
15.
KotsevaKWoodDDe BackerGDe BacquerDPyoralaKKeilU. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil2009; 16(2): 121–137.
16.
KotsevaKWoodDDe BackerGDe BacquerDPyoralaKKeilU. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet2009; 373(9667): 929–940.
17.
WensingMLudtSCampbellSVan LieshoutJVolbrachtEGrolR. European Practice Assessment of Cardiovascular risk management (EPA Cardio): protocol of an international observational study in primary care. Implement Sci2009; 4(1): 3–3.
18.
YusufSHawkenSOunpuuSDansTAvezumALanasF. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet2004; 364(9438): 937–952.
19.
Hippisley-CoxJPringleMCaterRCouplandCMealA. Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD. Br J Gen Pract2005; 55(514): 369–375.
20.
KetolaESipilaRMakelaMKlockarsM. Quality improvement programme for cardiovascular disease risk factor recording in primary care. Qual Saf Health Care2000; 9(3): 175–180.
21.
RafterNWellsSStewartASelakVWhittakerRBramleyD. Gaps in primary care documentation of cardiovascular risk factors. N Z Med J2008; 121(1269): 24–33.
22.
GlasgowREOryMGKlesgesLMCifuentesMFernaldDHGreenLA. Practical and relevant self-report measures of patient health behaviors for primary care research. Ann Fam Med2005; 3(1): 73–81.
23.
SheerinIHamiltonGHumphreyAScraggA. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand. N Z Med J2007; 120(1261): U2714–U2714.
WhitlockEPOrleansCTPenderNAllanJ. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med2002; 22(4): 267–284.
26.
GoldsteinMGWhitlockEPDePueJ. Multiple behavioral risk factor interventions in primary care. Summary of research evidence. Am J Prev Med2004; 27(2 Suppl): 61–79.
27.
SteptoeADohertySRinkEKerrySKendrickTHiltonS. Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. Commentary: Treatment allocation by the method of minimisation. BMJ1999; 319(7215): 943–948.
28.
GlasgowREEmontSMillerDC. Assessing delivery of the five ‘As’ for patient-centered counseling. Health Promot Int2006; 21(3): 245–255.
29.
Hippisley-CoxJPringleMCrownNMealAWynnA. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ2001; 322(7290): 832–832.
30.
CruzISernaCRealJGalindoGGascoEGalvanL. Ischemic heart disease and primary care: identifying gender-related differences. An observational study. BMC Family Practice2008; 9(1): 60–60.
31.
SuttonMElderRGuthrieBWattG. Record rewards: the effects of targeted quality incentives on the recording of risk factors by primary care providers. Health Econ2010; 19(1): 1–13.
32.
de LusignanS. An educational intervention, involving feedback of routinely collected computer data, to improve cardiovascular disease management in UK primary care. Methods Inf Med2007; 46(1): 57–62.
